Product Information:

ZETRO 500mg Tablets contain Cefpodoxime Proxetil 500mg, a high-strength formulation of a third-generation oral cephalosporin antibiotic. It works by inhibiting bacterial cell wall synthesis, providing broad-spectrum bactericidal activity against Gram-positive and Gram-negative pathogens, including Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis.

This dose is typically reserved for more severe or refractory community-acquired infections where higher systemic concentrations are needed.

Uses of (ZETRO 500MG TABLETS):

1. Moderate to severe community-acquired pneumonia
2. Complicated urinary tract infections (e.g., pyelonephritis)
3. Acute bacterial sinusitis or bronchitis unresponsive to lower doses
4. Uncomplicated skin and soft tissue infections with risk of resistant organisms
5. Gonorrhea (as a single high-dose regimen in select protocols)

Key Benefits of (ZETRO 500MG TABLETS):

1. Higher dose ensures adequate tissue penetration for serious infections
2. Oral alternative to injectable antibiotics in outpatient settings
3. Twice-daily dosing maintains effective serum levels
4. Broad coverage against common resistant respiratory and urinary pathogens

How To Use (ZETRO 500MG TABLETS):

1. Take with food to significantly enhance absorption (bioavailability increases by ~50%).
2. Swallow whole with water—do not crush or chew.
3. Complete the full prescribed course, even if symptoms improve early.
4. Typical adult dosage:
5. Severe respiratory or urinary infections: 500mg every 12 hours for 7–10 days
6. Gonorrhea (off-label/high-dose): Single 400–500mg dose (per local guidelines)

⚠️ Note: Standard maximum daily dose of cefpodoxime is usually 400mg/day; 500mg tablets may represent a local high-dose formulation—use only under medical supervision.

When Not to Use (ZETRO 500MG TABLETS):

Do not use if you have:

1. Hypersensitivity to cefpodoxime, other cephalosporins, or penicillins
2. History of anaphylaxis to beta-lactam antibiotics
3. Severe renal impairment (CrCl <30 mL/min)—requires significant dose reduction

❗ Important: Cefpodoxime 500mg is not commonly available globally—verify appropriateness with your physician.

Side Effects of (ZETRO 500MG TABLETS):

Common:

1. Diarrhea, nausea, abdominal pain
2. Headache, dizziness
3. Rash, vaginal candidiasis

Less common:

1. Elevated liver enzymes
2. Eosinophilia, transient neutropenia

Serious (rare):

1. Clostridioides difficile-associated diarrhea (CDAD)—persistent watery diarrhea with fever/cramps
2. Anaphylaxis or severe skin reactions (e.g., Stevens-Johnson syndrome)
3. Seizures (risk increases with high doses or renal impairment)
4. Discontinue and seek emergency care if breathing difficulty, severe rash, or bloody stools occur.

Dosage Adjustments:

1. Renal impairment (CrCl 30–50 mL/min): Reduce to 250mg once daily
2. CrCl <30 mL/min: Avoid or use only under specialist care
3. Elderly: Adjust based on renal function
4. Children: Not recommended—use suspension instead

Who It’s For (ZETRO 500MG TABLETS):

Adults with severe or treatment-resistant bacterial infections requiring intensified oral cephalosporin therapy, under close medical supervision.

Warnings & Precautions:

1. Use only for bacterial infections confirmed or strongly suspected
2. Monitor for CDAD if diarrhea develops during or after treatment
3. Avoid unnecessary use to prevent antimicrobial resistance
4. Cross-reactivity with penicillins possible (~5–10%)

Drug Interactions:

1. Antacids, H2 blockers, PPIs: May reduce absorption—administer 2 hours apart
2. Probenecid: May increase cefpodoxime levels
3. Oral contraceptives: Antibiotics may reduce efficacy—use backup contraception
4. Anticoagulants: Theoretical risk of increased bleeding—monitor INR
5. Always inform your doctor about all medications.

Additional Information:

Store below 30°C in a dry place, protected from light and moisture. Keep out of reach of children. Do not use after the expiration date. Available by prescription only in Pakistan.